Biogen trial of ALS drug fails main goal, but company says data are encouraging, Health News, ET HealthWorld
By Deena Beasley A late-stage trial of Biogen Inc’s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary measures and…
